The natural course of otitis media (OM) in most children is acute and self-limiting; however, approximately 10-20% of children can experience persistent or recurrent OM. Determining the host factors that influence outcome of OM will help us design better therapies. This study focused on the role of Toll-like receptor 2 (TLR2) in a pneumococcal OM mouse model.
o titis media (OM) is one of the most common pediatric infectious disease, and 50 to 80% of children have had OM at least once by age of 3 y in developed country (1, 2) . The natural course of OM in most children is acute and selflimiting (3) . Approximately 10 to 20% of children, however, can experience recurrent or persistent OM and resultantly suffer long-term hearing loss due to scarring of the ME conductive apparatus or sensorineural damage to the inner ear (4, 5) . Streptococcus pneumoniae (Spn), one of the most common pathogens associated with OM, is responsible for 19 to 74% of total episodes (6, 7) . Antibiotic use is, up till now, the major treatment of OM (8) . However, the increasing pneumococcal resistance and the emergence of multiple resistant Spn have led to a review of the antibiotic treatment of children with OM (1, (9) (10) (11) . Therefore, it is urgent to explore alternative therapies based on new insights into the pathophysiology of OM (3) .
As the best characterized class of pattern recognition receptor family, Toll-like receptors (TLRs) recognize the pathogenassociated molecular patterns of invading bacteria and regulate the production of cytokines and chemokines that orchestrate the recruitment of neutrophils and macrophages to clear invading bacteria at the site of infection (12, 13) . Clinical studies have revealed that the deficiency of IRAK-4 and MyD88, which are important adapter proteins of TLRs signaling pathway, was associated with a selective predisposition to pneumococcal infections in children (14) (15) (16) . Furthermore, the susceptibility of pneumococcal sepsis and meningitis in MyD88 -/-mice were significantly increased (17, 18) . These findings suggest TLRs signaling pathway plays an important role in host defense against pneumococcal infections. Among the defined 10 members of human TLRs, the Toll-like receptor 2 (TLR2), which locates in the plasma membrane of mucosal epithelial cells and innate immune cells, is activated by pneumococcal cell wall components, such as lipoteichoic acid and lipoproteins (19) , has been proved to induce inflammatory response and enhance pneumococcal phagocytosis and intracellular killing in leucocytes (20) . During pneumococcal pneumonia, TLR2 -/-mice exhibited slightly reduced levels of proinflammatory cytokines and unaffected Spn clearance (21) . In a model of pneumococcal meningitis, however, TLR2 -/-mice showed significantly reduced early leucocyte influx and impaired Spn clearance, as well as higher susceptibility to aggravated disease progression (22) . These paradoxical results indicate that the role of TLR2 in pneumococcal infections depends on distinct tissue microenvironment (23) .
To date, an in vitro research has revealed that pneumococcal peptidoglycan-polysaccharides can activate TLR2 expression in mouse ME epithelial cells through NF-κB signaling pathway (24) . The TLR2 mRNA expression in ME effusion of children with OM also increased (25) . More importantly, genetic Figure 1 . Expression of ME TLR2 during pneumococcal OM. ME TLR2 mRNA expression were determined using qRT-PCR (a) and semi-quantitative PCR (b) at 1 and 3 d after Spn infection. Mock: PBS-treated ME. Data are combined from three independent experiments with at least six mice in each group. Values are expressed relative to PBS-treated group and represent mean log 2 ± SD. ME TLR2 protein expression were determined using immunofluorescence at 1 d (c) and 3 d (d) after Spn infection. Mock: PBS-treated ME (e). IgG: nonspecific stain control for the upper row TLR2 stain (f). Red represents TLR2 protein and blue for cell nucleus. Scale bar = 50 μm. Original magnification: ×40. -/-mice. In WT mice, an exudate with inflammatory cells was noted in the ME cavity from 12 h (a), and this change reached the most prominent at 3 d (c). Thereafter, the exudate became to weaken from 5 d (g) and almost disappeared at 14 d (i). TLR2 -/-mice exhibited similar pathological changes with WT mice from 12 h to 3 d (d-f). However, at 5 to14 d after Spn infection, the MEs of TLR2 -/-mice showed a persistent inflammatory cell infiltration and ME mucous thickening compared with WT mice (j-l). ME, middle ear; TM, tympanic membrane. Scale bar = 500 μm. Original magnification: ×4. polymorphisms in TLRs and its downstream signal molecules, like TNFα, IL-6 and IL-10, have been proved to be associated with the recurrence and persistence of OM (26, 27) . Taken together, we inferred that TLR2 likely plays an important role in the pathogenesis of pneumococcal OM.
To investigate the role of TLR2 in pneumococcal OM, we established a mouse model of OM induced by Spn and compared the dynamics of ME pathologic change, inflammatory response and bacterial clearance between WT and TLR2 -/-mice.
RESULTS

ME TLR2 Expression Is Upregulated During Pneumococcal OM
Using qRT-PCR, we found that TLR2 mRNA was constitutively expressed in healthy ME and markedly enhanced following infection with pneumococci (Figure 1a,b) . Compared with PBS controls, Spn-infected mice were found to be nearly 100-fold upregulated in terms of TLR2 mRNA at 1 d and 8-fold at 3 d after Spn infection, respectively (Figure 1b) . Using immunofluorecence, we found that TLR2 protein expression in the surface epithelium of ME was also increased gradually and became evident at 3 d (Figure 1c-f) , which was correlated with TLR2 mRNA expression.
ME Pathological Changes in TLR2 -/-Mice Are Persistent After Spn Infection
To investigate the role of TLR2 in pathogenesis of OM, we compared the ME response to Spn in WT mice and TLR2 -/-mice. As depicted in Figure 2a -f, exudate with inflammatory cells began to appear within 12 h and nearly filled up the entire ME cavity of WT and TLR2 -/-mice at 3 d after Spn inoculation. In WT mice, the exudate decreased gradually from 5 d and almost disappeared at 14 d (Figure 2g-i) . During this period, however, the ME cavity of TLR2 -/-mice was still filled with considerable inflammatory cells and exudate, accompanied by the obvious pathological manifestations of tympanic membrane and ME mucosa (Figure 2j-l) . By comparing the pathological changes of ME mucosa near the eustachian tube orifice between WT and TLR2 -/-mice, we found that both of them exhibited similar inflammatory performance like vasodilation and leukocytic infiltration and mucosal hyperplasia in the early stage of Spn infection (12 h (Figure 2 ) and indicates the prolonged ME inflammation in TLR2 -/-mice. In the early stage, however, no similar significant differences between WT and TLR2 -/-group were observed (Figure 4a,c) . Taken together, these results indicate that deficiency of TLR2 signal delays the recovery of pneumococcal OM, but have little effect during the early initiation phase of ME inflammation.
TLR2 Contributes to Spn Clearance in ME Cavity
MELF was used to evaluate the kinetics of ME infection by quantitative culture. The density of Spn in MELF of WT mice decreased gradually over the observation period and almost Figure 3 . Dynamics of pathologic change in ME mucosa. Representative hemotoxylin and eosin staining of ME mucosa from WT and TLR2 -/-mice.
-/-mice. (m) ME mucosal thickness of WT and TLR2 -/-mice at different time point after Spn inoculation. Black fill columns, WT mice; no fill columns, TLR2 -/-mice. n = 16 ears per group per time point. *P < 0.05 and **P < 0.01 vs. WT mice. Values represent means ± SD. Scale bar = 100 μm. Original magnification: ×20. 
TLR2 in pneumococcal otitis media
Articles fell below the limit of detection (13/16 ears) at 7 d after inoculation (Figure 5a ). In contrast, Spn in MELF of TLR2 -/-mice were steadily recovered and significantly outnumbered that of WT group during the late stage of OM (5 and 7 d, Figure 5a ). Immunofluorescence staining of MELF cytospin preparations showed that many intact pneumococci located in ME cavity of TLR2 -/-mice at 5 and 7 d, while only small amount of pneumococcal debris was observed in WT mice (Figure 5b) , which is consistent with bacterial quantitative culture. Meanwhile, with the clearance of Spn, the inflammatory cells in WT mice showed significant degeneration and consequently few survived with intact morphology, which was different from TLR2 -/-mice. These findings suggest that TLR2 deficiency impairs the ability of Spn clearance and leads to a persistent ME inflammation.
Macrophage Recruitment Is Reduced in ME Cavity of TLR2 -/-Mice
Neutrophils and macrophages have been confirmed as important host effector cells to clear Spn at the site of infection. At 1 d after Spn inoculation, the majority of ME inflammatory cells in WT and TLR2 -/-mice were neutrophils (over 95%, CD11b (Figure 6a,c) ; Parallelly, the macrophages in WT mice also out numbered those in TLR2 -/-mice at 3 d, except for the neutrophils (Figure 6b) . Consistently, our histopathology results showed that less macrophages were observed in the ME cavity of TLR2
-/-mice than WT mice at 3 d (Figure 6d) .
DISCUSSION
The heterogeneity of ME infection's outcome among different children is a long-standing clinical challenge, but the mechanism underlying this phenomenon is still unclear. In this study, we established a mouse model of pneumococcal OM via transbullar injection and found that TLR2 expression in WT mice ME was markedly upregulated. In contrast to WT mice, TLR2 -/-mice showed a prolonged ME inflammation and persistent ME pathological changes (leukocytic infiltration in ME cavity and ME mucosal hyperplasia) at the late stage of pneumococcal OM, which correlated with the impaired pneumococcal clearance in ME cavity. We also found that macrophage recruitment of TLR2 -/-mice was significantly reduced during ME pneumococcal infection.
It has been documented that different pattern recognition receptors play important roles in host defense against pneumococcal infection of different organs. In early research, we evaluated mRNA expression profile of TLR2, TLR4, TLR9, NOD2, and NLRP3, which were involved in recognition of Spn (23) , in ME after Spn challenge (unpublished data). We found that upregulation of TLR2 mRNA, not others, was the most significant. We also confirmed an increased expression of TLR2 protein in ME mucosa by immunofluorescence, which is consistent with the finding of pneumococcal peptidoglycanpolysaccharides stimulating ME epithelial cells in vitro (24) . In this study, TLR2 -/-mice exhibited impaired Spn clearance as well as continuous ME inflammation, suggesting an indispensable role of TLR2 signaling for the resolution of OM, albeit no death occurred in the entire observation period. The apparent discrepancy may be explained by the following reasons: first, pneumococcal strain used in our study was the clinical isolate 31693 (serotype 19F, which is most frequently serotype isolated from OM patients and proved to be noninvasive (29) ) with a dose of 5 × 10 4 CFUs per ear, much less than Han's 1 × 10 6 CFUs per ear. Second, we adopted transbullar injection method to induce OM in the mouse model, which is under a direct view and can reduce the damage to cochlea significantly (30) .
We found no significant difference in the quantity of inflammatory cells and the levels of proinflammatory cytokines like TNF-α, IL-6, and IL-1β in MELF between WT and TLR2 -/-mice at 1 d post-Spn inoculation, suggesting that TLR2 did not play an important role in activating ME inflammatory response during pneumococcal OM. Indeed, several studies have proved that apart from TLR2, other pattern recognition receptors also get involved in recognizing invading Spn and leading to production of pro-inflammatory cytokines. For instance, TLR9 detects pneumococcal DNA containing unmethylated CpG motifs within endosomes (31) and lysozyme-digested pneumococcal peptidoglycan fragments are sensed by NOD2 within cytoplasm (32) . Our prior studies have demonstrated that IL-17A promotes Spn clearance by inducing the recruitment and apoptosis of neutrophils through a p38 MAPK signaling pathway and thus plays an important role in the development of pneumococcal OM (33) . In present study, however, there was no significant difference between WT and TLR2 -/-mice regarding concentrations of IL-17A in MELF, indicating that TLR2 signaling was not essential for IL-17A production during pneumococcal OM.
Zhang et al. previously reported that TLR2 -/-mice exhibit prolonged pneumococcal carriage and delayed macrophage recruitment in the nasopharynx, with neutrophil recruitment surprisingly unaffected, indicating a critical role for TLR2-mediated signaling in maintaining macrophage recruitment during pneumococcal colonization (34) . Probably the ME cavity and the nasopharynx sharing a substantially similar immunological microenvironment due to the adjacent anatomic location, these findings are consistent with the results in this study. As an important cellular mediator of innate immune defense, macrophage not only have the ability to engulf and kill invading pathogens directly, but also can produce numerous regulatory cytokines or ingest the aged neutrophils to assist a rapid and effective removal of pathogens by other immune effector cells (35, 36) . Besides, they also can present digested pathogen antigens to the corresponding helper T cell to initiate the adaptive immune response (37) . It has been reported that macrophage is essential for defense against Listeria monocytogenes, Mycobacterium tuberculosis, and Cryptococcus neoformans infection in murine model (38) . More importantly, in association with the depletion of macrophage with administration of Cl 2 MDP liposomes, there was a significantly diminished clearance of Spn in the nasopharynx at both 7 and 28 d after inoculation (34) . Thus, we hypothesize the impaired Spn clearance correlates with reduced macrophage recruitment in TLR2 -/-mice. In summary, our present results demonstrate that TLR2-mediated macrophage recruitment promotes the clearance of Spn in ME and thus contributes to the recovery of pneumococcal OM, shedding light on the potential of TLR2 as a novel strategy for OM treatment. However, the molecular mechanism of chemokine expression accounting for the TLR2-mediated macrophage recruitment during pneumococcal OM needs a further clarification. 
METHODS
Mice
Bacterial Strain
Streptococcus pneumonia clinical isolate 31693 (serotype 19F) was obtained from the National Center for Medical culture Collections (CMCC, Beijing, China) and grown in casein hydrolysate plus yeast extract (C+Y) medium at 37 °C in 5% CO 2 until mid-log phase (OD 600 = 0.4 to 0.5). After centrifugation, the pneumococcal pellet was washed and resuspended to a density of 1 × 10 7 CFUs/ml as previously described (33) .
Mouse Model of Experimental Otitis Media
The mouse model of OM was established via transbullar injection followed by the method described previously (39, 40) . In brief, mice were anesthetized with an intraperitoneal injection of ketamine hydrochloride (0.020 mg/g of body weight) and xylazine (0.013 mg/g). Through a ventral midline incision in the neck, the tympanic bulla was exposed bilaterally after blunt dissection. The bony wall of bilateral bulla was fenestrated using a 25-gauge needle and a total of 5 × 10 4 CFU Spn in ~5 μl was injected slowly into the ME cavity with a thinner needle. A mock control cohort of mice was inoculated with an equivalent volume of PBS alone. After that, the skin incision was sutured.
Quantitative Real-Time PCR
The tympanic bullae of WT mice, which encompasses the ME cavity was harvested at indicated time and then spilt longitudinally into dorsal and ventral halves. ME epithelium lining the ME cavity and effusions were lysed and collected with 700 μl RLT lysis buffer from RNeasy mini kit (Qiagen, Valencia, CA). After that, total RNA was isolated from the lysates using the RNeasy mini kit according to manufacturer's protocol (33) . cDNA was reverse transcribed using PrimeScript RT reagent Kit with gDNA Eraser (Takara Bio, Kusatsu, Japan). qPCR reactions based on SYBR green detection were performed using SYBR Premix Ex Taq II (Takara Bio) on an ABI PRISM 7500 sequence detection system (Applied Biosystems, Foster City, CA), and quantitative comparisons were made using the ΔΔC T 
WT TLR2
−/− Mice were sacrificed and intracardiacally perused with 10 ml sterile PBS. The tympanic bullae were harvested and spilt into dorsal and ventral halves as described above. The exposed ME space was lavaged three times with 40 μl sterile PBS containing 5% fetal calf serum and total ME lavage fluid (MELF, ~120 μl) was collected. For enumeration of pneumococcal numbers, 10 μl MELF was serially diluted (10-fold) in sterile PBS and 10 μl samples of those dilutions was plated on Columbia sheep blood agar plates. The limit of detection was 120 CFU (2.08Log 10 ) per ME. When no colonies were detected, the number of Spn was assumed to be slightly under our limit of detection (2.0Log 10 bacteria in the ME). Another 10 μl MELF was added to 190 μl 1% acetic acid solution for total cell quantification based on standard morphological criteria using a blood cell counting plate. Residual MELF was centrifuged at 500 g for 10 min and supernatant for cytokine measurement was collected and stored at −70 °C until use.
ELISA TNF-α, IL-6, IL-1β, and IL-17A in the MELF of WT and TLR2 -/-mice at 1 and 7 d after Spn inoculation were determined with commercially available ELISA kits from R&D systems (Quantikine; Minneapolis) according to the manufacturer's instructions.
Flow Cytometry
The MELF of five mice from each group at 1 and 3 d after Spn inoculation were pooled, centrifuged at 500 g. The cell pellets were treated with RBC lysis buffer (Biolegend, San Diego, CA) and nonspecific binding was blocked with Mouse BD Fc Block in stain buffer (BD Pharmingen, Franklin Lakes, NJ). A cocktail of fluorophore-conjugated rat anti-mouse cell surface antibodies included APC-CD45 (BD Pharmingen), PE-Cy5-F4/80 (eBioscience, San Diego, CA), FITCLy6G (BD Pharmingen), PE-CD11b (BD Pharmingen), and their isotype antibodies were added for 45 min on the ice. After that, the cells were washed three times and resuspended in stain buffer prior to FACS analysis on a BD FACS Calibur flow cytometer (BD Biosciences, San Jose, CA).
Immunofluorescence
For TLR2 expression, the ME paraffin sections were deparaffinized, rehydrated, and incubated with 0.05% trypsin solution (Invitrogen, Carlsbad, CA) for 20 min at 37 °C to unmask antigens. After being washed in PBS, the sections were blocked with 5% normal donkey serum in PBS for 2 h at room temperature, and then incubated with rabbit anti-mouse TLR2 polyclonal antibody (1:200; Merck Millipore, Kenilworth, NJ) overnight at 4 °C. After the sections were further washed in PBS, a Alexa Fluor 594-conjugated donkey anti-rabbit IgG (1:800; Jackson ImmunoResearch, West Grove, PA) was added for 1 h at room temperature. For pneumococcal clearance, MELF was pooled from at least four mice, 100 μl of that was spun onto slides at 700 rpm for 5 min, desiccated for 15 min. After fixed in 2% PFA for 10 min, the cytospin preparations were blocked with 5% normal donkey serum, and then incubated with rabbit anti-pneumococcal polysaccharide polyclonal antibody (1:1,000; Staten Serum Institute, Denmark) as well as goat anti-mouse neutrophil elastase polyclonal antibody (1:200; Santa Cruz Biotechnology, Dallas, TX). Secondary antibodies were Alexa Fluor 488-conjugated donkey anti-rabbit IgG and Alexa Fluor 594-conjugated donkey anti-goat IgG (both1:800; Jackson ImmunoResearch). The slides were washed in PBS and counterstained with DAPI (1:1000; Invitrogen). Immunoflurescence images were collected using Nikon ECLIPSE 80i.
Statistical Analyses
All statistical analysis was performed using GraphPad prism software version 5.01 for Windows (GraphPad, La Jolla, CA). For analysis of CFU data between WT and TLR2 -/-group, Mann-Whitney U-test was performed. For analysis of all other data, unpaired t-test was performed. P < 0.05 was considered statistically significant. Anti-sense primer:5′-TTTGCACTGGTACGTGTTGAT-3′
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